Rikshospitalets forskningsseminar

Inflammation in cardiovascular disease; towards new diagnostic and therapeutic tools


Program

14:30-14:35 Geir Christensen; Center for Heart Failure Research and Institute for Experimental Medical Research, Oslo University Hospital Ullevål
Opening remarks and presentation of Center for Heart Failure Research
 
14:35-14:55Torbjørn Omland; Department of Internal Medicine, Akershus University Hospital and Center for Heart Failure Research
Biomarkers in cardiovascular disease; current status and prospects for improved risk assessment and diagnosis
 
14:55-15:10Øystein Sandanger; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet and Center for Heart Failure Research
Innate immunity in cardiovascular disease; an “ancient system” with novel interest for cardiologists
 
15:10-15:25 Vigdis Hillestad; Institute for Experimental Medical Research, Oslo University Hospital Ullevål and Center for Heart Failure Research
Cytokine-systems regulated by the innate immune system are putative targets for treatment of diastolic heart failure

 
15:25-15:40Break
 
15:40-15:55 Ingebjørg Seljeflot; Center for Clinical Heart Research and Department of Cardiology, Oslo University Hospital Ullevål and Center for Heart Failure Research
IL-18 predictivity of clinical events and relation to adipose tissue

 
15:55-16:15Lars Gullestad; Department of Cardiovascular Medicine, Oslo University Hospital Rikshospitalet and Center for Heart Failure Research
An update on anti-inflammatory therapy in heart failure; is it ready for clinical use?

 

Organizers:
Jan-Bjørn Osnes, Department of Pharmacology, University of Oslo and Center for Heart Failure Research
Geir Christensen, Institute for Experimental Medical Research, Oslo University Hospital Ullevål and Center for Heart Failure Research
Lars Gullestad and Pål Aukrust, Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet

 

 

 

 

 

 

 

 

 

 

Webmaster Vidar, IEMF